Lotus Health Group Co.

Lotus Health Group Co. has seen a significant increase today, contrasting with the broader market's performance. Despite recent challenges, including a notable decline over the past week and month, the company has outperformed the market over the past year, showcasing strong profitability metrics within the FMCG sector.

Lotus Health Group Co. saw a notable stock decline today, contrasting with the positive performance of the China Shanghai Composite. Despite a strong annual profit increase and a significant market capitalization, the company has faced steep weekly and monthly losses, indicating challenges in its recent performance relative to the broader market.

Lotus Health Group Co. faced a notable decline in its stock price, dropping significantly today and over the past week and month. Despite recent challenges, the company has shown strong long-term performance, with a substantial increase over the past year, outperforming the broader market. Key financial metrics indicate a high valuation.

Lotus Health Group Co. saw a notable decline in its stock price, contrasting with the modest gain of the China Shanghai Composite. Despite a positive monthly performance, the company has struggled over the past year. It maintains a large market capitalization and has demonstrated strong profit growth, though efficiency in inventory management needs improvement.

Lotus Health Group Co. saw a significant increase in stock performance on June 30, 2026, reaching an intraday high. Over the past month, the stock has surged substantially, with impressive year-to-date growth. Despite facing challenges in the past year, the company maintains a strong market capitalization and solid return on equity.

Lotus Health Group Co. saw a significant stock price drop today, contrasting with the overall market's modest gain. Despite a strong monthly performance, the company has faced a cumulative decline over the past week and underperformed annually, even as profits increased. Its market capitalization stands at CNY 18,716 million.

Lotus Health Group Co. has seen notable stock activity, with significant gains over various timeframes, including a year-to-date increase of 145.15%. The company, operating in the FMCG sector, has a market capitalization of CNY 18,716 million, reflecting a shift in investor sentiment despite previous underperformance.

Lotus Health Group Co. has seen notable stock performance, with significant gains over the past week and month, and a substantial year-to-date increase. However, the company has struggled over the past year, contrasting with broader market trends. It holds a strong market capitalization within the FMCG sector.

Lotus Health Group Co. has experienced notable stock performance, with significant gains over various time frames. Despite a challenging year, the company maintains a strong market capitalization and key financial metrics that indicate a premium valuation, positioning it well within the FMCG sector.

Lotus Health Group Co. has seen notable stock activity, rising significantly today and achieving an intraday high. Over the past week, the stock has increased substantially, with impressive annual returns that outpace the broader market. The company maintains a large market capitalization and a strong return on equity.

Lotus Health Group Co. has seen notable stock activity, rising significantly today and achieving an intraday high. Over the past week, the company has shown substantial growth, with impressive year-to-date and three-year performance figures, despite underperforming relative to the market over the past year. Financial metrics indicate strong operational efficiency.

Lotus Health Group Co. has experienced notable stock performance, achieving an intraday high while the broader market declined. The company has shown strong year-to-date growth and impressive long-term gains, although it has faced challenges over the past year. Its financial metrics indicate a premium valuation within the FMCG sector.

Lotus Health Group Co. has seen a significant stock increase today, contrasting with a decline in the broader market. Over the past year, the company has outperformed the China Shanghai Composite, with notable gains in the FMCG sector, despite recent short-term challenges. Its financial metrics indicate strong profitability and a premium valuation.

Lotus Health Group Co. faced a decline today, with its stock hitting an intraday low amid a slight drop in the broader market. Despite a year-to-date increase, the company has struggled over the past year, raising concerns about its market position within the FMCG sector. Key financial metrics indicate a high valuation.

Lotus Health Group Co. saw a notable decline in its stock today, contrasting with the broader market's performance. Despite a year-to-date increase, the company has struggled over the past year. Key financial metrics indicate a high valuation and operational efficiency, with a market capitalization of CNY 18,449 million.

Lotus Health Group Co. faced a significant stock price decline on May 28, 2026, reaching an intraday low. Despite this, the company has shown strong year-to-date performance, outperforming the China Shanghai Composite. Key financial metrics indicate a high valuation, with profits increasing despite recent challenges.

Lotus Health Group Co. has seen notable stock activity, rising significantly today and over the past week and month. Despite impressive year-to-date gains, the company faces challenges with a relatively high valuation and a less favorable annual performance compared to the broader market. The FMCG sector remains volatile.

Lotus Health Group Co. has seen a notable increase in its stock price, outperforming the broader market significantly. Over the past week and month, the stock has shown impressive gains, while year-to-date returns highlight its strong performance. However, the company faces challenges with its valuation metrics and recent annual performance.

Lotus Health Group Co. saw its stock price decline today amid a broader market downturn, despite a strong performance over the past month. The company has faced challenges over the past year, with negative returns, while maintaining a notable market capitalization and key financial metrics indicating a high valuation.